✦ LIBER ✦

The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1

✍ Scribed by Chan, Eunice H Y; Nousiainen, Marjaana; Chalamalasetty, Ravindra B; Schäfer, Anja; Nigg, Erich A; Silljé, Herman H W

Book ID: 110069503
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 283 KB
Volume: 24
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1208445

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MARKK, a Ste20-like kinase, activates th

MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1

✍ Timm, T. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 560 KB

Caspase-mediated activation and inductio

Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1

✍ Graves, J. D. 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 439 KB

Activation of the tumour suppressor kina

Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD

✍ Baas, A.F. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 468 KB

Role of the tumor suppressor RASSF2 in r

Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity

✍ Hoogeun Song; Sangphil Oh; Hyun Jung Oh; Dae-Sik Lim 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Yeast Cdc42 GTPase and Ste20 PAK-like ki

Yeast Cdc42 GTPase and Ste20 PAK-like kinase regulate Sho1-dependent activation of the Hog1 MAPK pathway

✍ Raitt, D. C. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 520 KB

Mutant human tumor suppressor p53 modula

Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-κB, but not c-Jun N-terminal kinase and activated protein-1

✍ Anthony P. Gulati; Yang-Ming Yang; David Harter; Asok Mukhopadhyay; Bharat A. Ag 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

## Abstract The roles of the mitogen‐activated kinase protein (MAPK) pathway, nuclear factor‐kappa B (NF‐κB), and activator protein‐1 (AP‐1) in cellular responses to growth factors and mitogen are well established. However, the manner by which these proliferative pathways are affected by the tumor